Year: All Releases20192018201720162015201420132012 September 26, 2018 Mersana Therapeutics to Present at Upcoming Investor Conferences PDF Version September 25, 2018 Mersana Therapeutics Presents New Preclinical Data on XMT-1536 at the International Association for the Study of Lung Cancer (IASLC) 19th World Conference on Lung Cancer PDF Version September 17, 2018 Mersana Announces FDA Lifts Partial Clinical Hold for XMT-1522 PDF Version August 30, 2018 Mersana Therapeutics to Present at Upcoming Investor Conferences PDF Version August 14, 2018 Mersana Therapeutics Announces Second Quarter 2018 Financial Results and Provides Business Updates PDF Version August 8, 2018 Mersana Therapeutics to Present at the Wedbush PacGrow Healthcare Conference PDF Version August 8, 2018 Mersana Therapeutics to Host Conference Call Announcing Second Quarter 2018 Financial Results and Business Updates PDF Version July 19, 2018 Mersana Therapeutics Announces Partial Clinical Hold for XMT-1522 Clinical Trial PDF Version June 4, 2018 Mersana Presents Interim Dose-Escalation Data on XMT-1522 in Select Cancers at ASCO 2018 PDF Version May 31, 2018 Mersana Therapeutics to Present at the Jefferies Global Healthcare Conference PDF Version Pagination First page First Previous page Previous … Page 2 Current page 3 Page 4 Page 5 … Next page Next Last page Last
